Skip to content

SAUSSURE PHARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SAUSSURE PHARMA

BE 0740.545.114
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€9,410
2024 · €9,927-€518
Equity
€54,488
2024 · €45,078+€9,410
Cash
€34,568
2024 · €37,362-€2,794
Balance sheet total
€509,667
2024 · €520,162-€10,495

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€30,000

    down €30,000 (-20.0%), from €150,000 to €120,000

  • Receivables within one year +€17,869

    up €17,869 (+6.9%), from €259,044 to €276,912

    of which Trade receivables: +€24,084

  • Stocks and contracts +€5,734

    up €5,734 (+8.9%), from €64,464 to €70,198

Equity and liabilities
  • Debts after one year -€39,297

    down €39,297 (-21.9%), from €179,427 to €140,130

  • Trade debts +€17,577

    up €17,577 (+7.7%), from €227,277 to €244,854

  • Profit (loss) carried forward +€9,410

    up €9,410 (+26.8%), from €35,078 to €44,488

Income statement
  • Gross operating margin -€1,165

    down €1,165 (-2.4%), from €47,892 to €46,727

  • Financial charges -€495

    down €495 (-8.4%), from €5,889 to €5,394

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €9,927
Gross operating margin -€1,165
Depreciation +€440
Other operating charges -€47
Financial income -€336
Financial charges +€495
Taxes +€96
Result 2025 €9,410

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€36,112
Investment €0
Financing -€38,906
Cash 2024 €37,362
Net result for the year +€9,410
Depreciation +€31,205
Stocks and contracts -€5,734
Receivables within one year -€17,869
Deferred charges and accrued income +€98
Trade debts +€17,577
Tax, wage and social debts +€2,155
Accrued charges and deferred income -€731
Debts after one year -€39,297
Current portion of long-term debt +€391
Cash 2025 €34,568
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €520,162 €509,667 -€10,495 -2.0%
Fixed assets 21/28 €158,387 €127,182 -€31,205 -19.7%
Intangible fixed assets 21 €150,000 €120,000 -€30,000 -20.0%
Tangible fixed assets 22/27 €8,387 €7,182 -€1,205 -14.4%
Furniture and vehicles 24 €313 - -€313
Other tangible fixed assets 26 €8,073 €7,182 -€892 -11.0%
Current assets 29/58 €361,775 €382,486 +€20,710 +5.7%
Stocks and contracts in progress 3 €64,464 €70,198 +€5,734 +8.9%
Stocks 30/36 €64,464 €70,198 +€5,734 +8.9%
Amounts receivable within one year 40/41 €259,044 €276,912 +€17,869 +6.9%
Trade receivables 40 €134,020 €158,104 +€24,084 +18.0%
Other amounts receivable 41 €125,024 €118,809 -€6,215 -5.0%
Cash at bank and in hand 54/58 €37,362 €34,568 -€2,794 -7.5%
Deferred charges and accrued income 490/1 €906 €808 -€98 -10.8%
Total equity and liabilities 10/49 €520,162 €509,667 -€10,495 -2.0%
Equity 10/15 €45,078 €54,488 +€9,410 +20.9%
Contributions 10/11 €10,000 €10,000 = 0.0%
Profit (loss) carried forward 14 €35,078 €44,488 +€9,410 +26.8%
Amounts payable 17/49 €475,084 €455,180 -€19,905 -4.2%
Amounts payable after more than one year 17 €179,427 €140,130 -€39,297 -21.9%
Financial debts 170/4 €179,427 €140,130 -€39,297 -21.9%
Amounts payable within one year 42/48 €294,664 €314,788 +€20,123 +6.8%
Current portion of amounts payable after more than one year 42 €38,906 €39,297 +€391 +1.0%
Financial debts 43 €25,000 €25,000 = 0.0%
Other loans 439 €25,000 €25,000 = 0.0%
Trade debts 44 €227,277 €244,854 +€17,577 +7.7%
Suppliers 440/4 €227,277 €244,854 +€17,577 +7.7%
Taxes, remuneration and social security 45 €3,451 €5,606 +€2,155 +62.4%
Taxes 450/3 €3,451 €5,606 +€2,155 +62.4%
Other amounts payable 47/48 €30 €30 = 0.0%
Accrued charges and deferred income 492/3 €994 €263 -€731 -73.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €31,646 €31,205 -€440 -1.4%
Other operating charges 640/8 €577 €625 +€47 +8.2%
Gross operating margin 9900 €47,892 €46,727 -€1,165 -2.4%
Operating profit (loss) 9901 €15,669 €14,897 -€772 -4.9%
Financial income 75/76B €3,599 €3,262 -€336 -9.3%
Recurring financial income 75 €3,599 €3,262 -€336 -9.3%
Financial charges 65/66B €5,889 €5,394 -€495 -8.4%
Recurring financial charges 65 €5,889 €5,394 -€495 -8.4%
Profit (loss) for the period before taxes 9903 €13,379 €12,765 -€614 -4.6%
Income taxes 67/77 €3,451 €3,355 -€96 -2.8%
Profit (loss) for the period 9904 €9,927 €9,410 -€518 -5.2%
Profit (loss) for the period to be appropriated 9905 €9,927 €9,410 -€518 -5.2%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.